Ceftazidime
Tazicef and generics; previously available as Fortaz
Antibiotic, cephalosporin (third generation)
| B | 1 | Yes | Yes | No |
| Key |
- Injection: 1, 2, 6 g
- Frozen injection: 1 g/50 mL 4.4% dextrose, 2 g/50 mL 3.2% dextrose (iso-osmotic solutions)
- Contains 2.3 mEq Na/g drug
Dosing
- Neonate (IV/IM):
- Postnatal age ≤7 days: 50 mg/kg/dose Q12 hr
- Postnatal age >7–28 days:
- <1000 g:
- Postnatal age 8–14 days: 50 mg/kg/dose Q12 hr
- Postnatal age 15–28 days: 50 mg/kg/dose Q8 hr
- ≥1000 g: 50 mg/kg/dose Q8 hr
- <1000 g:
- Meningitis:
- Postnatal age ≤7 days: 50 mg/kg/dose Q8–12 hr
- Postnatal age >7 days: 50 mg/kg/dose Q8 hr
- Infant (>1 mo), child and adolescent (IV/IM):
- Mild/moderate infection:100–150 mg/kg/24 hr ÷ Q8 hr; max. dose: 6 g/24 hr
- Meningitis: 150–200 mg/kg/24 hr ÷ Q8 hr ( max. dose: 6 g/24 hr)
- Serious Pseudomonas infections: 200–300 mg/kg/24 hr ÷ Q8 hr ( max. dose: 12 g/24 hr)
- Cystic fibrosis: 200–400 mg/kg/24 hr ÷ Q6–8 hr ( max. dose: 12 g/24 hr)
- Adult (IV/IM): 1–2 g/dose Q8–12 hr; max. dose: 6 g/24 hr
Notes
- Use with caution in penicillin-allergic patients or in presence of renal impairment. Good Pseudomonas coverage and CSF penetration. May cause rash, liver enzyme elevations, and false-positive urine-reducing substance (e.g., Clinitest, Benedict's solution, or Fehling's solution) and Coombs test. Enzymatic glucose oxidase urinary glucose tests (e.g., Clinistix or Tes-Tape) are recommended. Probenecid increases serum ceftazidime levels. Adjust dose in renal failure (see Chapter 31 ). Nonconvulsive status epilepticus, neuromuscular excitability, and myoclonia may occur with elevated levels of ceftazidime.
Citation
Hughes, Helen K., and Lauren K. Kahl, editors. "Ceftazidime." Harriet Lane Handbook, 23rd ed., Elsevier, 2024. Harriet Lane, www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309399/2/Ceftazidime.
Ceftazidime. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook. Elsevier; 2024. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309399/2/Ceftazidime. Accessed August 6, 2026.
Ceftazidime. (2024). In Hughes, H. K., & Kahl, L. K. (Eds.), Harriet Lane Handbook (23rd ed.). Elsevier. https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309399/2/Ceftazidime
Ceftazidime [Internet]. In: Hughes HKH, Kahl LKL, eds. Harriet Lane Handbook. Elsevier; 2024. [cited 2026 August 06]. Available from: https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309399/2/Ceftazidime.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ceftazidime
ID - 309399
ED - Hughes,Helen K,
ED - Kahl,Lauren K,
BT - Harriet Lane Handbook
UR - https://www.unboundmedicine.com/harrietlane/view/Harriet_Lane_Handbook/309399/2/Ceftazidime
PB - Elsevier
ET - 23
DB - Harriet Lane
DP - Unbound Medicine
ER -

Harriet Lane Handbook

